Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|22|3|540-546

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.22, Iss.3, 2015-03, pp. : 540-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substantia nigra neuromelanin‐MR imaging differentiates essential tremor from Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 953-959

John Wiley & Sons Inc

Access to resources Recommend Favorite

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 945-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Longitudinal study of the substantia nigra in Parkinson disease: A high‐field 1H‐MR spectroscopy imaging study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1400-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 1408-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

MRSpectroscopy: ALongitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease?

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1304-1305

John Wiley & Sons Inc

Access to resources Recommend Favorite